MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Exploring Clinical and Neurophysiologic Predictors of Adaptive Deep Brain Stimulation Response in Parkinson’s disease

    T. Herrington, M. Beudel, J. Ostrem, S. Little, A. Ramirez-Zamora, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, L. Tonder, Y. Tan, R. Summers, S. Stanslaski, H. Bronte-Stewart (San Francisco, USA)

    Objective: To evaluate clinical and neurophysiologic characteristics that may predict a positive clinical response to adaptive deep brain stimulation (aDBS) in patients previously stable on…
  • 2025 International Congress

    Efficacy and Safety of IPX203 and Levodopa-Carbidopa Intestinal Gel (LCIG) Compared to Immediate-Release Carbidopa-Levodopa in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    M. Mustafa, A. Abunamoos, Y. Aljazi, F. Alnajjar, A. Sa’D, M. Alghaniem, K. Abuhananeh (Amman, Jordan)

    Objective: To conduct the efficacy and safety of IPX203, an extended-release carbidopa-levodopa formulation, and LCIG, a continuous levodopa infusion, compared to Immediate-Release Carbidopa-Levodopa (IR CD-LD)…
  • 2025 International Congress

    Evaluation of Local Field Potential-guided DBS-programming in a Parkinson’s disease outpatient clinic

    V. Zentsch, N. Warneke, I. Aymanns, D. Putzer, T. Huchtemann, T. Warnecke, I. Claus (Muenster, Germany)

    Objective: To evaluate potential use and applicability of local field potential-guided DBS-programming under real-life conditions in a Parkinson’s disease (PD) outpatient clinic. Background: Deep brain…
  • 2025 International Congress

    Computer Vision Quantification of Repeated Finger Tapping Demonstrates Aberrant Plasticity in Parkinson’s Disease

    D. Newbold, U. Kang (New York, USA)

    Objective: Test if symptoms of Parkinson's disease (PD) develop through aberrant plasticity. Background: Recent results in 6-hydroxydopamine-lesioned mice show that repeated performance of simple motor…
  • 2025 International Congress

    Correlations of catecholamine metabolites and alpha-synuclein by nigral stimulation in Parkinson’s disease model rat

    T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kuwabara (Chiba, Japan)

    Objective: We aimed to clarify the effects of substantia nigra (SN) stimulation on catecholamine levels and α-synuclein in PD model rats. Background: Catecholaminergic neurons are…
  • 2025 International Congress

    Reduced Falls With ND0612: Supportive Analyses From the BouNDless Phase 3 Study

    S. Isaacson, F. Stocchi, A. Ellenbogen, N. Lopes, N. Sasson, J. Pereira, O. Rascol (Boca Raton, USA)

    Objective: Explore potential reasons for the lower rates of falls with ND0612 vs immediate-release levodopa/carbidopa (IR-LD/CD) therapy reported in the BouNDless study. Background: Falls are…
  • 2025 International Congress

    The Role of Research and Genetics Educational Events in Parkinson’s Research: Overcoming Barriers in the Hispanic Community

    A. Coral-Zambrano, M. Rodriguez Violante, J. Orozco Velez, M. Inca Martinez, I. Mata, P. Hodges, R. de León (Miami, USA)

    Objective: To assess the impact of educational events that emphasize research and genetics as well as culturally adapted recruitment strategies on increasing Hispanic participation in…
  • 2025 International Congress

    Access to Allied Health Services by People Living with Parkinson’s Disease: A Qualitative Study

    C. Wong, S. Dennis, N. Allen, S. Paul (Camperdown, Australia)

    Objective: To determine the referral patterns of people with Parkinson’s disease (PwPD) to allied health from their perspective. Background: Allied health interventions can improve impairments…
  • 2025 International Congress

    A Systematic Site Selection Approach to Ensure Efficient and Diverse Participant Recruitment to a Large-Scale Multi-Arm, Multi-Stage Platform Trial for Parkinson’s

    G. Mills, M-L. Zeissler, O. Bandmann, R. Barker, J. Carpenter, S. Collins, J. Duffen, S. Gandhi, L. Houlden, C. Gonzalez-Robles, C. Mcalpine, K. Mcfarthing, C. Pugh, A. Schapira, A. Schrag, C. Shakeshaft, T. Foltynie, C. Carroll (London, United Kingdom)

    Objective: To select up to 40 delivery sites to successfully recruit and retain a participant population representative of people with Parkinson’s disease (PwP) in the…
  • 2025 International Congress

    The Feedback Loop: Illness Perceptions and Motor Complications in Parkinson’s

    V. Azoidou, L. Smith, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To explore the relationship between motor complications, illness perceptions and cognitive beliefs about symptoms in people with Parkinson's disease (PwP). Background: Around 50% PwP…
  • « Previous Page
  • 1
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley